控制的人类感染Mycobacterium结核病:临床试验的实际考虑
Chetan Seshadri1, JoAnne L Flynn2, Pauline Maiello2
1Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA; Seattle Tuberculosis Research Advancement Center, Seattle, WA, USA.
The Lancet. Microbe
|January 26, 2026
概括
使用工程Mycobacterium结核病菌株的受控人类感染模型 (CHIM) 可以加速疫苗开发. 这种方法解决了伦理问题,并概述了安全有效的结核病CHIM研究的实际考虑.
科学领域:
- 传染性疾病 传染性疾病
- 疫苗学 疫苗学 疫苗学
- 微生物学 微生物学
背景情况:
- 结核病 (TB) 仍然是全球主要的传染性死亡原因,其复杂的临床结果在动物身上模拟不佳.
- 控制的人类感染模型 (CHIM) 提供了加速的疫苗开发,但由于安全问题,它面临着对Mycobacterium结核病的伦理障碍.
- 细菌工程的最新进展已经产生了更安全的M.结核病菌株,这可能使伦理CHIM研究成为可能.
研究的目的:
- 解决进行肺部Mycobacterium结核病CHIM研究的实际和伦理考虑.
- 概述必要的安全措施,包括对M.结核病CHIM的剂量优化和风险减轻.
- 通过使用CHIMs定义关键的临床,微生物学,免疫学和放射学终点,以开发有效的结核病疫苗.
主要方法:
- 对M.结核病CHIM在不同环境中的伦理考虑的审查.
- 分析安全参数,包括挑战剂量和保护第三方.
- 优先考虑疫苗有效性评估的相关终点.
主要成果:
- 工程安全菌株的M.结核病可能会克服以前对CHIMs的伦理异议.
- 为优化M.结核病CHIM的安全性和最大限度地降低风险提出了实际指导方针.
- 提出了选择关键终点的框架,以最大限度地提高CHIMs对结核病疫苗研究的有用性.
结论:
- 使用先进的细菌工程,CHIMs提供了一个可行的策略,以加速结核病疫苗的开发.
- 仔细考虑道德问题和安全协议对于成功实施至关重要.
- 确定可靠的终点对于最大限度地提高这些模型的科学回报和翻译影响至关重要.
更多相关视频
09:02An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
Published on: February 17, 2014
20.2K
10:10A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
19.5K
相关概念视频
01:16Clinical Trials
10.3K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.3K
01:11Clinical Trials: Overview
4.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.9K
01:12Statistical Software for Data Analysis and Clinical Trials
1.5K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.5K
01:25Endocarditis II: Clinical Features of Infective Endocarditis
478
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
478
01:12Trial and Error and Algorithm
401
A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
401
01:22Design Consideration
567
Designing a structure involves a series of considerations, primarily the material's ultimate strength, calculated through tests that measure changes under increased force until the material reaches its breaking point or limit. The ultimate load, where the material breaks, is divided by its original cross-sectional area, resulting in the ultimate normal stress or strength. The ultimate shearing stress is another significant factor taken into account.
The factor of safety is another key...
The factor of safety is another key...
567